Tempest Therapeutics (TPST) Other financing activities (2018 - 2025)

Tempest Therapeutics has disclosed Other financing activities across 7 years of filings, most recently posting $1.5 million for Q4 2025.

• In Q4 2025, Other financing activities rose 145200.0% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $3.3 million (up 977.85% YoY), while the FY2025 annual figure was $3.3 million, up 977.85% from the prior year.
• Other financing activities came in at $1.5 million for Q4 2025 at Tempest Therapeutics, down from $1.8 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $7.3 million in Q2 2022 to a low of -$1000.0 in Q3 2022.
• Average Other financing activities over 4 years is $846538.5, with a median of $42000.0 recorded in 2021.
• Year-over-year, Other financing activities sank 102.04% in 2022 and surged 145200.0% in 2025.
• Over 4 years, Other financing activities stood at $42000.0 in 2021, then slumped by 97.62% to $1000.0 in 2022, then plunged by 200.0% to -$1000.0 in 2024, then surged by 145200.0% to $1.5 million in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $1.5 million in Q4 2025, $1.8 million in Q3 2025, and $34000.0 in Q1 2025.